HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: the [email protected] study.

AbstractINTRODUCTION:
Dyslipidemia is a significant contributor to the elevated CVD risk observed in type 2 diabetes mellitus. We assessed the prevalence of dyslipidemia and its association with glucose metabolism status in a representative sample of the adult population in Spain and the percentage of subjects at guideline-recommended LDL-C goals.
MATERIAL AND METHODS:
The [email protected] study is a national, cross-sectional population-based survey of 5728 adults.
RESULTS:
A total of 4776 subjects were studied. Dyslipidemia was diagnosed in 56.8% of subjects; only 13.2% of subjects were treated with lipid lowering drugs. Lipid abnormalities were found in 56.8% of Spanish adults: 23.3% with high LDL-C, 21.5% high TG, 35.8% high non-HDL-C, and 17.2% low HDL-C. Most normal subjects showed an LDL-C ≤ 3.36 mmol/l. Pre-diabetics presented similar proportion when considering a goal of 3.36 mmol/l, but only 35% of them reached an LDL-C goal ≤ 2.6 mmol/l. Finally, 45.3% of diabetics had an LDL-C ≤ 2.6 mmol/l, and only 11.3% achieved an LDL-C ≤ 1.8 mmol/l.
CONCLUSIONS:
Our study demonstrates a high prevalence of dyslipidemia in the adult Spanish population, and a low use of lipid-lowering drugs. Moreover, the number of subjects achieving their corresponding LDL-C goal is small, particularly in subjects at high cardiovascular risk, such as diabetics.
AuthorsSergio Martinez-Hervas, Rafael Carmena, Juan F Ascaso, Jose T Real, Luis Masana, Miguel Catalá, Joan Vendrell, José Antonio Vázquez, Sergio Valdés, Inés Urrutia, Federico Soriguer, Manuel Serrano-Rios, Gemma Rojo-Martínez, Gemma Pascual-Manich, Emilio Ortega, Inmaculada Mora-Peces, Edelmiro Menéndez, Maria T Martínez-Larrad, Alfonso López-Alba, Ramón Gomis, Albert Goday, Juan Girbés, Sonia Gaztambide, Josep Franch, Elías Delgado, Conxa Castell, Luis Castaño, Roser Casamitjana, Alfonso Calle-Pascual, Elena Bordiú
JournalClinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis (Clin Investig Arterioscler) 2014 May-Jun Vol. 26 Issue 3 Pg. 107-14 ISSN: 1578-1879 [Electronic] Spain
PMID24461346 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Sociedad Española de Arteriosclerosis. Published by Elsevier España. All rights reserved.
Chemical References
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hypolipidemic Agents
  • Glucose
Topics
  • Adolescent
  • Adult
  • Aged
  • Cardiovascular Diseases (etiology)
  • Cholesterol, HDL (blood)
  • Cholesterol, LDL (blood)
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 (blood)
  • Dyslipidemias (complications, drug therapy, epidemiology)
  • Female
  • Glucose (metabolism)
  • Humans
  • Hypolipidemic Agents (therapeutic use)
  • Male
  • Middle Aged
  • Prediabetic State (blood)
  • Prevalence
  • Risk Factors
  • Spain (epidemiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: